Actavis Loses to FDA in ADHD Drug Ruling Courthouse News Service Actavis Elizabeth LLC claimed that it should be able to sell its generic version of the ADHD drug, because Shire Pharmaceuticals' Vyvanse was not a "new ... and more » |
Court rebuffs Actavis on Vyvanse FiercePharma A US district court judge in DC has upheld an FDA decision to grant five years of market exclusivity to Shire's ADHD drug Vyvanse (lisdexamfetamine), ... Shire: District Court Upholds FDAs Grant of 5-Year Exclusivity Wall Street Journal Actavis Loses to FDA in ADHD Drug Ruling Courthouse News Service Shire given market exclusivity for ADHD drug Drug Store News (blog) FOXBusiness - Pharma Times all 36 news articles » |